Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
1994
Y 4.EN 2/3: 103-113
Available at Government Documents Microfiche
Formats
| Format | |
|---|---|
| BibTeX | |
| MARCXML | |
| TextMARC | |
| MARC | |
| DublinCore | |
| EndNote | |
| NLM | |
| RefWorks | |
| RIS |
Items
Details
Title
Orphan drug reauthorization : hearing before the Subcommittee on Health and the Environment of the Committee on Energy and Commerce, House of Representatives, One Hundred Third Congress, second session on H.R. 4160, a bill to amend the Federal Food, Drug, and Cosmetic Act, the Public Health Service Act, and the Orphan Drug Act to revise the provisions of such acts relating to orphan drugs, June 16, 1994.
Corporate Author
ISBN
0160449006
Publication Details
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1994.
Language
English
Description
iii, 117 p. ; 23 cm.
Call Number
Y 4.EN 2/3: 103-113
GPO Item No.
1019-A
Note
Distributed to some depository libraries in microfiche.
Shipping list no.: 94-0313-P.
"Serial no. 103-113."
Shipping list no.: 94-0313-P.
"Serial no. 103-113."
Bibliography, etc. Note
Includes bibliographical references.
Record Appears in